INTRON BIOTECHNOLOGY, INC. financial statements, including revenue, expenses, and profit
The total revenue of 048530 for the last quarter is 1.52 B KRW, and it's 25.91% higher compared to the previous quarter. The net income of Q4 24 is -800.52 M KRW.